Aura Biosciences (AURA US)

Analysis

Health Care • United States

Aura Biosciences, Inc. develops nano-technology for treatment of cancer. The Company specializes in the production of nanoparticles designed to mimic viral structures, bypass immune systems, absorb efficiently into cells, and target cancerous tissue. Aura Biosciences serves the healthcare, biotechnology, and pharmaceutical industries.

Refresh

Company Event • 11 Aug 2026 04:00 • Upcoming

Add To Calendar

Q2 2026

Company Event • 28 May 2026 01:30 • Latest

7th Annual Oncology Innovation Summit: Insights for ASCO & EHA

Company Event • 20 May 2026 00:00

H.C. Wainwright 4th Annual BioConnect Investor Conference

Company Event • 12 May 2026 04:00 • Upcoming

Add To Calendar

Corporate presentation

Company Event • 12 May 2026 04:00 • Upcoming

Add To Calendar

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Q2 2026

7th Annual Oncology Innovation Summit: Insights for ASCO & EHA

H.C. Wainwright 4th Annual BioConnect Investor Conference

Corporate presentation

Q1 2026